BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21178133)

  • 1. Collaborations among academia, government, and industry in the diagnostics space: barriers and some ideas for solutions.
    Evans G; Austin F
    Sci Transl Med; 2010 Dec; 2(63):63mr3. PubMed ID: 21178133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Academic/Industry challenges for medical device development.
    Linehan JH; Chaney A
    Sci Transl Med; 2010 Dec; 2(63):63mr6. PubMed ID: 21178136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing translational research collaborations.
    Portilla LM; Evans G; Eng B; Fadem TJ
    Sci Transl Med; 2010 Dec; 2(63):63cm30. PubMed ID: 21178130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Training the translational scientist.
    Jackson RD; Gabriel S; Pariser A; Feig P
    Sci Transl Med; 2010 Dec; 2(63):63mr2. PubMed ID: 21178132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reaping the benefits of biomedical research: partnerships required.
    Portilla LM; Alving B
    Sci Transl Med; 2010 Jun; 2(35):35cm17. PubMed ID: 20538616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunities and barriers in the age of team science: strategies for success.
    Sellers TA; Caporaso N; Lapidus S; Petersen GM; Trent J
    Cancer Causes Control; 2006 Apr; 17(3):229-37. PubMed ID: 16489530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regulatory science for drug evaluation].
    Toyoshima S
    Nihon Rinsho; 2010 Nov; 68(11):2135-41. PubMed ID: 21061545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Industry-Academia Partnership: The Synthesis and Solid-State Pharmaceutical Centre (SSPC) as a Collaborative Approach from Molecule to Medicine.
    McGlacken GP; Hayes S; Maguire AR; O'Halloran J; Hodnett K
    Chemistry; 2018 Jan; 24(2):499-503. PubMed ID: 29235704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerating technology transfer: new relationships for academia, industry and government.
    Satava RM
    Stud Health Technol Inform; 1998; 50():1-6. PubMed ID: 10180523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulatory science forum--its background and goal].
    Uchiyama M
    Eisei Shikenjo Hokoku; 1993; (111):140-1. PubMed ID: 7920557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TB diagnostics in India: creating an ecosystem for innovation.
    Engel N; Kenneth J; Pai M
    Expert Rev Mol Diagn; 2012 Jan; 12(1):21-4. PubMed ID: 22133116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Grants4Targets - an innovative approach to translate ideas from basic research into novel drugs.
    Lessl M; Schoepe S; Sommer A; Schneider M; Asadullah K
    Drug Discov Today; 2011 Apr; 16(7-8):288-92. PubMed ID: 21129498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics in Europe: barriers and opportunities.
    Gurwitz D; Zika E; Hopkins MM; Gaisser S; Ibarreta D
    Public Health Genomics; 2009; 12(3):134-41. PubMed ID: 19204415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Symposium review: drug discovery, development and clinical research in academia.
    Vlaar CP; Hernández L
    P R Health Sci J; 2009 Sep; 28(3):268-73. PubMed ID: 19715120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge translation in tri-sectoral collaborations: An exploration of perceptions of academia, industry and healthcare collaborations in innovation adoption.
    Ii SS; Fitzgerald L; Morys-Carter MM; Davie NL; Barker R
    Health Policy; 2018 Feb; 122(2):175-183. PubMed ID: 29191387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The critical path initiative: leveraging collaborations to enhance regulatory science.
    Barratt RA; Bowens SL; McCune SK; Johannessen JN; Buckman SY
    Clin Pharmacol Ther; 2012 Mar; 91(3):380-3. PubMed ID: 22343813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Better infrastructure: industry-academia partnerships--a marriage of convenience?
    Abraham E
    Crit Care Med; 2009 Jan; 37(1 Suppl):S159-64. PubMed ID: 19104217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief of the Canadian Society for Clinical Investigation to the science and technology review.
    Clin Invest Med; 1995 Feb; 18(1):80-90. PubMed ID: 7768069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Introduction: "The scope of this forum" and "the necessity of introduction of compassionate use system in Japan"].
    Fujiwara Y
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):281-3. PubMed ID: 17301543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer chemoprevention and cancer preventive vaccines--a call to action: leaders of diverse stakeholder groups present strategies for overcoming multiple barriers to meet an urgent need.
    Herberman RB; Pearce HL; Lippman SM; Pyenson BS; Alberts DS
    Cancer Res; 2006 Dec; 66(24):11540-9. PubMed ID: 17158189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.